Immunohistochemical expression of SIRT1 was evaluated in patients with diffuse large B-cell lymphoma (DLBCL), using a 2 mm tissue microarray core, and SIRT1 was expressed in 74% (77/104) of patients [34]. Here, SIRT1 is linked to diffuse large B-cell lymphoma.